Iovance Biotherapeutics, Inc. IOVA
6.90 USD -0.41 (-5.61%)
Regular-session close
6.99 +0.09 +1.25%
After hours · Nov 20, 7:59 PM ET
6.77 Day range 7.40
2.08 52-week range 15.37
- YTD
- +152.75%
- 1 year
- +216.51%
Revenue & Expenses
Revenue by
Revenue Profit Costs
Latest period ending Dec 31, 2025 · select a line to chart its full history
Annual income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 263.50M | 164.07M | 1.19M | 0 | 0 | |
| 263.50M | 164.07M | 1.19M | 0 | 0 | |
| 173.18M | 93.25M | 1.03M | 0 | 0 | |
| 90.32M | 70.82M | 156.00K | 0 | 0 | |
| 493.67M | 466.10M | 460.71M | 398.88M | 342.70M | |
| 300.27M | 276.23M | 333.19M | 294.78M | 259.04M | |
| 152.32M | 152.27M | 106.10M | 104.10M | 83.66M | |
| -403.36M | -395.28M | -460.56M | -398.88M | -342.70M | |
| -2.07M | -2.83M | -3.48M | 0 | 0 | |
| -390.98M | -372.18M | -444.04M | -395.89M | -342.25M | |
| -390.98M | -372.18M | -444.04M | -395.89M | -342.25M | |
| -390.98M | -372.18M | -444.04M | -395.89M | -342.25M | |
| -390.98M | -372.18M | -444.04M | -395.89M | -342.25M | |
| -1.09 | -1.28 | -1.89 | -2.49 | -2.23 | |
| -1.09 | -1.28 | -1.89 | -2.49 | -2.23 | |
| -1.09 | -1.28 | -1.89 | -2.49 | -2.23 | |
| -393.05M | -375.00M | -447.52M | -395.89M | -342.25M | |
| -393.05M | -375.00M | -447.52M | -395.89M | -342.25M | |
| 357.35M | 289.88M | 235.13M | 159.26M | 153.41M | |
| 357.35M | 289.88M | 235.13M | 159.26M | 153.41M |
